Avestar Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Sell |
3,951
-730
| -16% | -$63.7K | 0.02% | 325 |
|
|
2025
Q1 | $320K | Sell |
4,681
-1,161
| -20% | -$79.3K | 0.03% | 318 |
|
|
2024
Q4 | $454K | Buy |
5,842
+1,766
| +43% | +$137K | 0.04% | 279 |
|
|
2024
Q3 | $273K | Buy |
4,076
+1,308
| +47% | +$87.7K | 0.03% | 346 |
|
|
2024
Q2 | $314K | Sell |
2,768
-162
| -6% | -$18.4K | 0.03% | 300 |
|
|
2024
Q1 | $406K | Buy |
2,930
+490
| +20% | +$68K | 0.04% | 244 |
|
|
2023
Q4 | $303K | Buy |
+2,440
| New | +$303K | 0.03% | 270 |
|
|
2023
Q3 | – | Sell |
-1,965
| Closed | -$253K | – | 329 |
|
|
2023
Q2 | $253K | Buy |
1,965
+97
| +5% | +$12.5K | 0.04% | 242 |
|
|
2023
Q1 | $217K | Buy |
1,868
+5
| +0.3% | +$581 | 0.04% | 260 |
|
|
2022
Q4 | $211K | Buy |
+1,863
| New | +$211K | 0.04% | 250 |
|
|
2019
Q3 | – | Sell |
-80
| Closed | -$2K | – | 353 |
|
|
2019
Q2 | $2K | Hold |
80
| – | – | ﹤0.01% | 679 |
|
|
2019
Q1 | $2K | Buy |
+80
| New | +$2K | ﹤0.01% | 652 |
|